PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN (IR) IN PATIENTS WITH ADVANCED SOLID TUMOURS

被引：0
|
作者：
Boven, E. [1 ]
Massard, C. [2 ]
Armand, J. P. [3 ]
Tillier, C. [1 ]
Hartog, V. [1 ]
Brega, N. M. [4 ]
Contouriotis, A. M. [5 ]
Law, C. N. J. [5 ]
Soria, J. [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Inst Gustave Roussy, Villejuif, France
[3] Inst Claudius Regaud, Toulouse, France
[4] Pfizer Global Res & Dev, Oncology, Milan, Italy
[5] Pfizer Inc, Global Res & Dev, La Jolla, CA USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [31] Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
    de Jonge, M. J. A.
    Dumez, H.
    Kitzen, J. J. E. M.
    Beuselinck, B.
    Verweij, J.
    Courtney, R.
    Battista, A.
    Brega, N.
    Schoffski, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (09) : 1328 - 1335
  • [32] Clofarabine administration weekly to adult patients with advanced solid tumors in a phase I dose-finding study.
    Cunningham, CC
    Nemunaitis, J
    Senzer, N
    Vukelja, S
    Richards, D
    Vukovic, V
    Weitman, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 647S - 647S
  • [33] Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors
    Patnaik, A
    Warner, E
    Michael, M
    Egorin, MJ
    Moore, MJ
    Siu, LL
    Fracasso, PM
    Rivkin, S
    Kerr, I
    Litchman, M
    Oza, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 3677 - 3689
  • [34] A PHASE I AND DOSE-FINDING STUDY OF LENVATINIB (E7080) IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
    Yamamoto, N.
    Nokihara, H.
    Yamada, Y.
    Honda, K.
    Wakui, H.
    Sasaki, T.
    Yusa, W.
    Tamura, T.
    ANNALS OF ONCOLOGY, 2013, 24
  • [35] Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors
    Rubin, EH
    Rothermel, J
    Tesfaye, F
    Chen, TL
    Hubert, M
    Ho, YY
    Hsu, CH
    Oza, AM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9120 - 9129
  • [36] SUNITINIB (SU) WITH CISPLATIN (P) AND CAPECITABINE (X) OR OXALIPLATIN (O) AND X (XELOX) IN ADVANCED GASTRIC CANCER (GC) - A PHASE I, DOSE-FINDING STUDY
    Park, S. R.
    Lee, K.
    Oh, D.
    Park, Y. I.
    Roh, E.
    Khosravan, R.
    Lu, D. R.
    Tursi, J. M.
    Lechuga, M. J.
    Bang, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 254 - 255
  • [37] A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
    Bhuvaneswari Ramaswamy
    Tanios Bekaii-Saab
    Larry J. Schaaf
    Gregory B. Lesinski
    David M. Lucas
    Donn C. Young
    Amy S. Ruppert
    John C. Byrd
    Kristy Culler
    Diedre Wilkins
    John J. Wright
    Michael R. Grever
    Charles L. Shapiro
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 151 - 158
  • [38] A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
    Ramaswamy, Bhuvaneswari
    Bekaii-Saab, Tanios
    Schaaf, Larry J.
    Lesinski, Gregory B.
    Lucas, David M.
    Young, Donn C.
    Ruppert, Amy S.
    Byrd, John C.
    Culler, Kristy
    Wilkins, Diedre
    Wright, John J.
    Grever, Michael R.
    Shapiro, Charles L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (01) : 151 - 158
  • [39] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with docetaxel in patients with advanced solid tumors
    Robert, F.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    Vermeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Verkh, L.
    Traynor, A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3514S - 3515S
  • [40] Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours
    Iñaki F. Trocòniz
    María J. Garrido
    Cristina Segura
    Josep-María Cendrós
    Paola Principe
    Concepción Peraire
    Rosendo Obach
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 727 - 735
12345